Oncodesign Precision Medicine SA (ALOPM)
EU
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
EUR (€) | EUR (€) | |
Return on Assets (%) | -2.515 | -46.233 |
Return on Equity (%) | -4.695 | -139.62 |
Return on Invested Capital (%) | -0.855 | -79.537 |
Operating Margin (%) | -20.138 | -904.198 |
Net Profit Margin (%) | -2.895 | -754.757 |
Book Value Per Share | 0.545 | 0.036 |
Earnings Per Share | -0.014 | -0.485 |
Cash Per Share | 0.805 | 0.019 |
Working Capital Per Share | 0.714 | 0.523 |
Operating Profit Per Share | 0.497 | 0.065 |
EBIT Per Share | -0.104 | -0.591 |
EBITDA Per Share | -0.104 | -0.591 |
Free Cash Flow Per Share | -0.037 | -0.5 |
Year End December 30 2023 | 2022 | 2023 |
---|---|---|
Current Ratio | N/A | N/A |
Quick Ratio | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A |
Shares Outstanding | 16.61M | 16.68M |
Market Cap | 13.64M |
Price to Earnings Ratio | -1.6 |
Price to Sales Ratio | 11.97 |
Price to Cash Ratio | 40.11 |
Price to Book Ratio | 7.38 |
Dividend Yield | - |
Shares Outstanding | 18.19M |
Average Volume (1 week) | 5.31k |
Average Volume (1 Month) | 11k |
52 Week Change | -61.61% |
52 Week High | 2.06 |
52 Week Low | 0.714 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.